Showing results (1101-1110 of 1,142) with videos related to
Sort By:
Pageof 115
Gut|April 15, 2026
CD16+ γδ T cells mediate antibody-dependent cellular cytotoxicity and associate with viral control in chronic hepatitis B virus infectionPaulina E Schröter, Katja Steppich, Laura Fernández Carrera, et al.Journal of Hepatology|January 29, 2022
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levelsMilan J Sonneveld, Shao-Ming Chiu, Jun Yong Park, et al.Gastroenterology|February 16, 2019
Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8+ T Cells and Evolve at the Population LevelHadi Karimzadeh, Muthamia M Kiraithe, Valerie Oberhardt, et al.Open Research Europe|August 5, 2024
Atacama Large Aperture Submillimeter Telescope (AtLAST) Science: Planetary and Cometary AtmospheresMartin Cordiner, Alexander Thelen, Thibault Cavalie, et al.JHEP Reports : Innovation in Hepatology|July 24, 2023
Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort studyMilan J Sonneveld, Shao-Ming Chiu, Jun Yong Park, et al.Gut|February 23, 2025
Multicentre randomised controlled trial of a self-assembling haemostatic gel to prevent delayed bleeding following endoscopic mucosal resection (PURPLE Trial)Jan Drews, Markus Zachäus, Tobias Kleemann, et al.Journal of Hepatology|November 13, 2024
HBV shows different levels of adaptation to HLA class I-associated selection pressure correlating with markers of replicationTatjana Schwarz, Johannes Ptok, Maximilian Damagnez, et al.Liver International : Official Journal of the International Association for the Study of the Liver|May 15, 2023
Quality-of-life scores improve after 96 weeks of PEG-IFNa-2a treatment of hepatitis D: An analysis of the HIDIT-II trialKatja Dinkelborg, Julia Kahlhöfer, Petra Dörge, et al.Open Research Europe|October 15, 2024
Atacama Large Aperture Submillimeter Telescope (AtLAST) science: Surveying the distant UniverseEelco van Kampen, Tom Bakx, Carlos De Breuck, et al.The Lancet. Gastroenterology & Hepatology|December 14, 2024
Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort studyKatrine P Lindvig, Katrine H Thorhauge, Johanne K Hansen, et al.Pageof 115